The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Comprehensive analyses of rectal cancer genomes to reveal copy number variations as potential predictor of induction therapy efficacy.
Julia Beck
Employment or Leadership Position - Chronix Biomedical
Stock Ownership - Chronix Biomedical
Research Funding - Chronix Biomedical
Jochen Gaedcke
No relevant relationships to disclose
Howard B. Urnovitz
Employment or Leadership Position - Chronix Biomedical
Stock Ownership - Chronix Biomedical
Research Funding - Chronix Biomedical
Kirsten Bornemann-Kolatzki
Employment or Leadership Position - Chronix Biomedical
Marian Grade
No relevant relationships to disclose
William Marvin Mitchell
Employment or Leadership Position - Chronix Biomedical (U)
Michael Ghadimi
No relevant relationships to disclose
Ekkehard Schütz
Employment or Leadership Position - Chronix Biomedical
Stock Ownership - Chronix Biomedical
Honoraria - Chronix Biomedical
Research Funding - Chronix Biomedical